Application of pharmaceutical composition in the process for preparing medicine to treat aspirin resistance

Abstract

The invention relates to the application of pharmaceutical composition in the process for preparing medicine to treat aspirin resistance wherein the composition comprises (by weightg ratio) Chinese angelica root 10-100mg, astragalus root 50-100mg, red peony root 10-50g, Ligusticum wallichii 20-100g, radix salvia miltiorrhiza 60-300g, cassia twig 10-100g, peach kernel 10-100g, safflower 10-100g, mulberry twigs 10-200g, achyranthes and cyathula root 10-200g, frankincense 10-150g, myrrh 10-150g, hooked uncaria 10-200g, earthworm 10-500g, buthus martensi kirsch 10-1000g, centipede 1-100 pieces, spatholobus stem 10-500g, leech 10-1000g.

Description

Technical field [0001] The invention belongs to the field of medicine, and specifically relates to the application of a pharmaceutical composition in the preparation of anti-aspirin resistance drugs. Background technique [0002] Aspirin, also aspirin or acetylsalicylic acid, has been used clinically for more than 80 years and is an ancient antipyretic and analgesic. In recent years, with the deepening of prostaglandin research, a new understanding of aspirin has been gained: in addition to traditionally used for antipyretic, analgesic, and anti-inflammatory, it is also used for anti-platelet aggregation. Clinical trials have shown that aspirin is an effective antiplatelet drug for primary prevention of high-risk patients with cardiovascular and cerebrovascular diseases, and it is also effective for secondary prevention of myocardial infarction and ischemic vascular events. [0003] However, in the current clinical use of therapeutic doses of aspiri...

AI Technical Summary

Problems solved by technology

[0026] However, there is no report on the research on the